Lindbrook Capital »

Aclaris Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $401 383 1.05
2023-09-30 $1.9k 284 6.85
2023-06-30 $353 34 10.38
2022-12-31 $3.3k 208 15.75
2022-09-30 $4.0k 239 16.74
2022-06-30 $3.0k 208 14.42
2022-03-31 $4.0k 208 19.23